EGFR and non-small cell lung carcinoma: In EGFR-mutated NSCLC, Wu et al. showed that DNMT1 promotes cell proliferation through methylating promoters, and thus, downregulating hMLH1 and hMSH2, which suppress the cell cycle [59].